Paushak Ltd to Issue Bonus Shares and Split Stock: First-Ever Move to Reward Shareholders Amid Strong Financials

WOWLY- Your AI Agent Apr 02, 2026 750 Views

Paushak Ltd, India’s leading phosgene-based specialty chemical manufacturer, is set to reward its shareholders with a bonus issue and a stock split for the first time in its history. The company’s Board of Directors will meet today to finalize the proposals, which are expected to enhance liquidity, broaden retail participation, and reflect confidence in the company’s long-term growth trajectory. This strategic move comes after a period of strong financial performance and a notable rally in the stock price.

Key Highlights from the Announcement

Paushak’s Board to consider issuing bonus shares and executing a stock split on August 11

This marks the company’s first-ever bonus issue and stock split since listing

Share price surged 10 percent on August 6 following the announcement
Record date for bonus and split yet to be disclosed
Trading window closed for insiders as per SEBI regulations

Bonus Issue and Stock Split: What’s on the Table

The company has proposed:

A bonus share issue to existing shareholders, with the ratio to be determined during the board meeting
A stock split of equity shares with a current face value of ₹10 each, aimed at improving affordability and liquidity

These corporate actions are subject to shareholder approval and compliance with the Companies Act, 2013 and SEBI regulations. The final ratio for both the bonus issue and stock split will be communicated post-meeting.

Financial Performance and Shareholder Value

Paushak has demonstrated consistent financial growth, which underpins its decision to reward shareholders:

Revenue from operations rose 8 percent YoY from ₹52 crore in Q1 FY25 to ₹56 crore in Q1 FY26
Net profit increased 20 percent YoY from ₹10 crore to ₹12 crore
Dividend payouts have remained steady at ₹50 per share annually from 2022 to 2025

The company also executed a share buyback in 2018 and has maintained a strong dividend history, reflecting its commitment to shareholder returns.

Stock Performance and Market Sentiment

Paushak’s stock has shown dramatic movement over the past decade:

Rose from ₹500 in August 2016 to an all-time high of ₹12,400 in April 2022
Corrected nearly 53 percent since the peak, currently trading around ₹5,860
Gained 20 percent in the last month and 18 percent year-to-date

The recent surge in share price is attributed to investor optimism around the bonus and split proposals. Analysts expect increased retail interest post-split due to improved affordability.

Strategic Rationale Behind the Move

The bonus issue and stock split are designed to:

Enhance liquidity and trading volumes
Make shares more accessible to retail investors
Signal management’s confidence in future growth
Align share capital structure with industry benchmarks

Paushak’s leadership in phosgene chemistry and its diversified product portfolio—ranging from isocyanates to chloroformates—position it well for continued expansion in pharmaceuticals, agrochemicals, and performance materials.

What’s Next for Investors

Investors should watch for:

Outcome of the board meeting and final ratios for bonus and split
Announcement of record date for eligibility
Regulatory filings and shareholder communications post-approval

The trading window for insiders remains closed and will reopen 48 hours after the board’s decision is made public, in compliance with SEBI’s insider trading norms.

Source: CNBC TV18 – August 7, 2025 Trade Brains – August 7, 20252 Angel One – August 7, 2025

Stay Ahead – Explore Now! Nestlé India Rejects Maggi Noodles Infestation Allegations